TipRanks
iX Biopharma Ltd. (SG:42C)
SGX:42C
Singapore Market
42C
iX Biopharma Ltd.
RESEARCH TOOLSreports
Want to see SG:42C full AI Analyst Report?

iX Biopharma Ltd. (42C) Ratios

25 Followers

iX Biopharma Ltd. Ratios

SG:42C's free cash flow for Q4 2025 was S$0.35. For the 2025 fiscal year, SG:42C's free cash flow was decreased by S$ and operating cash flow was S$-1.67. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 1.86 1.86 0.47 0.89 1.53
Quick Ratio
 1.74 1.74 0.37 0.71 1.40
Cash Ratio
 1.47 1.47 0.10 0.24 0.91
Solvency Ratio
 -0.69 -0.69 -0.85 -0.97 -0.96
Operating Cash Flow Ratio
 -0.56 -0.80 -0.42 -0.89 -1.07
Short-Term Operating Cash Flow Coverage
 -1.07 -1.52 -0.92 -2.63 -2.78
Net Current Asset Value
S$ 8.13MS$ 8.13MS$ -6.71MS$ -3.70MS$ 1.90M
Leverage Ratios
Debt-to-Assets Ratio
 0.22 0.22 0.52 0.36 0.17
Debt-to-Equity Ratio
 0.38 0.38 16.17 1.20 0.27
Debt-to-Capital Ratio
 0.27 0.27 0.94 0.55 0.21
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.80 0.33 0.03
Financial Leverage Ratio
 1.68 1.68 30.92 3.37 1.57
Debt Service Coverage Ratio
 -1.50 -1.50 -2.04 -3.24 -2.78
Interest Coverage Ratio
 -13.86 -13.86 -19.58 -16.71 -31.04
Debt to Market Cap
 <0.01 0.02 0.40 0.21 0.05
Interest Debt Per Share
 6.16 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 1.01 1.01 -0.56 -0.40 0.26
Profitability Margins
Gross Profit Margin
35.52%35.52%26.26%17.59%39.24%
EBIT Margin
-139.52%-139.52%-126.42%-160.14%-159.56%
EBITDA Margin
-128.89%-128.89%-115.42%-145.58%-143.85%
Operating Profit Margin
-139.52%-139.52%-80.92%-123.98%-142.25%
Pretax Profit Margin
-116.50%-116.50%-130.55%-167.56%-164.15%
Net Profit Margin
-116.64%-116.64%-130.57%-181.14%-162.61%
Continuous Operations Profit Margin
-116.64%-116.64%-130.57%-181.14%-162.61%
Net Income Per EBT
100.11%100.11%100.01%108.10%99.06%
EBT Per EBIT
83.51%83.51%161.34%135.15%115.40%
Return on Assets (ROA)
-30.89%-30.89%-89.87%-73.81%-38.57%
Return on Equity (ROE)
-81.85%-51.92%-2778.36%-248.71%-60.65%
Return on Capital Employed (ROCE)
-60.23%-60.23%-272.67%-102.00%-47.38%
Return on Invested Capital (ROIC)
-44.68%-44.68%-94.36%-73.00%-39.78%
Return on Tangible Assets
-30.89%-30.89%-92.07%-75.33%-39.03%
Earnings Yield
-1417.86%-2.27%-72.50%-48.50%-13.81%
Efficiency Ratios
Receivables Turnover
 3.48 3.48 4.01 4.40 4.37
Payables Turnover
 1.06 1.06 1.33 3.90 9.10
Inventory Turnover
 3.70 3.70 6.21 3.56 3.76
Fixed Asset Turnover
 0.96 0.96 1.16 0.78 0.72
Asset Turnover
 0.26 0.26 0.69 0.41 0.24
Working Capital Turnover Ratio
 1.52 3.57 -2.79 3.96 0.92
Cash Conversion Cycle
 -140.17 -140.17 -125.11 91.85 140.57
Days of Sales Outstanding
 104.98 104.98 91.07 82.94 83.58
Days of Inventory Outstanding
 98.54 98.54 58.76 102.57 97.12
Days of Payables Outstanding
 343.69 343.69 274.94 93.65 40.13
Operating Cycle
 203.52 203.52 149.84 185.50 180.70
Cash Flow Ratios
Operating Cash Flow Per Share
 -5.28 >-0.01 >-0.01 >-0.01 -0.01
Free Cash Flow Per Share
 -5.39 >-0.01 >-0.01 >-0.01 -0.01
CapEx Per Share
 0.11 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.02 1.01 1.05 1.04 1.09
Dividend Paid and CapEx Coverage Ratio
 -48.82 -69.19 -18.70 -22.99 -11.02
Capital Expenditure Coverage Ratio
 -48.82 -69.19 -18.70 -22.99 -11.02
Operating Cash Flow Coverage Ratio
 -0.96 -1.37 -0.64 -1.26 -1.77
Operating Cash Flow to Sales Ratio
 -0.81 -1.16 -0.48 -1.10 -1.30
Free Cash Flow Yield
-0.97%-2.29%-28.30%-30.73%-12.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -64.46 -43.98 -1.38 -2.06 -7.24
Price-to-Sales (P/S) Ratio
 85.35 51.40 1.80 3.73 11.77
Price-to-Book (P/B) Ratio
 0.04 22.88 38.32 5.13 4.39
Price-to-Free Cash Flow (P/FCF) Ratio
 -103.00 -43.64 -3.53 -3.25 -8.33
Price-to-Operating Cash Flow Ratio
 -0.10 -44.27 -3.72 -3.40 -9.09
Price-to-Earnings Growth (PEG) Ratio
 1.95 1.55 0.08 -0.17 -0.07
Price-to-Fair Value
 0.04 22.88 38.32 5.13 4.39
Enterprise Value Multiple
 -65.21 -38.87 -2.12 -2.96 -7.93
Enterprise Value
 575.99M 343.30M 19.02M 25.68M 67.42M
EV to EBITDA
 -65.21 -38.87 -2.12 -2.96 -7.93
EV to Sales
 84.05 50.09 2.45 4.31 11.40
EV to Free Cash Flow
 -101.42 -42.53 -4.81 -3.76 -8.07
EV to Operating Cash Flow
 -103.50 -43.14 -5.06 -3.92 -8.80
Tangible Book Value Per Share
 14.61 0.02 <0.01 <0.01 0.02
Shareholders’ Equity Per Share
 14.61 0.02 <0.01 <0.01 0.02
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 >-0.01 -0.08 <0.01
Revenue Per Share
 6.50 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 -7.59 >-0.01 -0.01 -0.01 -0.01
Tax Burden
 1.00 1.00 1.00 1.08 0.99
Interest Burden
 0.84 0.84 1.03 1.05 1.03
Research & Development to Revenue
 0.36 0.36 0.21 0.29 0.48
SG&A to Revenue
 0.88 1.39 0.86 0.72 0.99
Stock-Based Compensation to Revenue
 0.30 0.00 <0.01 -0.14 0.14
Income Quality
 0.94 1.00 0.37 0.61 0.80
Currency in SGD